Humanigen (STU:0KB1) COGS-to-Revenue : 0.00 (As of Mar. 2023)

View and export this data going back to 2014. Start your Free Trial

What is Humanigen COGS-to-Revenue?

Humanigen's Cost of Goods Sold for the three months ended in Mar. 2023 was €0.00 Mil. Its Revenue for the three months ended in Mar. 2023 was €0.21 Mil.

Humanigen's COGS to Revenue for the three months ended in Mar. 2023 was 0.00.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Humanigen's Gross Margin % for the three months ended in Mar. 2023 was N/A%.

Humanigen COGS-to-Revenue Historical Data

The historical data trend for Humanigen's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Humanigen COGS-to-Revenue Chart

Humanigen Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

COGS-to-Revenue

Get a 7-Day Free Trial

Humanigen Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
COGS-to-Revenue	Get a 7-Day Free Trial															-	-	-	-	-

Humanigen COGS-to-Revenue Calculation

Humanigen's COGS to Revenue for the fiscal year that ended in Dec. 2022 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	2.373
	=	0.00

Humanigen's COGS to Revenue for the quarter that ended in Mar. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	0.206
	=	0.00

Humanigen (STU:0KB1) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Humanigen's Gross Margin % for the three months ended in Mar. 2023 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	0 / 0.206
	=	N/A %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Humanigen COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Humanigen's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Humanigen (STU:0KB1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Humanigen Inc (STU:0KB1) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

830 Morris Turnpike, 4th Floor, Short Hills, NJ, USA, 07078

Website

https://www.humanigen.com

Humanigen Inc is a biopharmaceutical company engaged in the development of proprietary monoclonal antibodies for various oncology indications and to enhance T-cell therapies, making these treatments safer and cost-effective. It focuses on preventing the serious and potentially life-threatening side effects associated with chimeric antigen receptor T-cell (CAR-T) therapy. Its pipeline includes programs such as Lenzilumab, Ifabotuzumab, and HGen005. It has one segment, which is related to the development of pharmaceutical products.

Humanigen (STU:0KB1) Headlines

No Headlines